Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Gongwin Biopharm Holdings Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	893.47	273.59	671.51	454.12	707.23
Short-Term Investments	1,030	668.66	434.1	372.2	297.09
Trading Asset Securities	466.79	-	-	-	34.41
Cash & Short-Term Investments	2,390	942.25	1,106	826.33	1,039
Cash Growth	153.63%	-14.78%	33.80%	-20.45%	60.78%
Accounts Receivable	14.17	10.58	-	-	-
Other Receivables	12.31	4.52	4.25	0.06	0.21
Receivables	26.48	15.1	4.25	0.06	0.21
Inventory	3.59	11.93	0.21	-	-
Prepaid Expenses	12.89	11.36	11.11	-	-
Other Current Assets	0.02	138.42	215.88	93.74	21.34
Total Current Assets	2,433	1,119	1,337	920.12	1,060
Property, Plant & Equipment	330.89	118.32	245.05	246.76	136.97
Long-Term Investments	497.81	156.61	32.35	3.88	5.34
Other Intangible Assets	0.37	0.19	-	-	0.01
Other Long-Term Assets	120.3	121.17	7.47	1.12	1.42
Total Assets	3,382	1,515	1,622	1,172	1,204
Accounts Payable	0.21	0.29	-	-	-
Accrued Expenses	-	26.37	32.63	21.97	19.03
Short-Term Debt	110.63	75.02	134.55	113.06	29.28
Current Portion of Leases	3.21	2.12	5.01	1.99	4.7
Current Income Taxes Payable	15.7	15.13	15.44	15.2	-
Other Current Liabilities	52.41	7.44	3.62	2.54	2.66
Total Current Liabilities	182.16	126.36	191.26	154.75	55.66
Long-Term Leases	12.91	0.03	2.18	0.1	2.11
Long-Term Unearned Revenue	45.01	45.08	42.03	29.57	27.97
Other Long-Term Liabilities	41.76	32.06	13.24	0	-
Total Liabilities	281.84	203.53	248.7	184.43	85.75
Common Stock	1,275	1,133	1,131	1,099	1,093
Additional Paid-In Capital	3,500	1,644	1,634	1,061	1,045
Retained Earnings	-1,529	-1,441	-1,349	-1,094	-972.88
Treasury Stock	-166.61	-	-	-	-
Comprehensive Income & Other	27.14	-21.35	-24.77	-95.34	-71.36
Total Common Equity	3,107	1,315	1,392	970.72	1,093
Minority Interest	-6.2	-3.68	-18.58	16.74	25.21
Shareholders' Equity	3,100	1,312	1,373	987.45	1,118
Total Liabilities & Equity	3,382	1,515	1,622	1,172	1,204
Total Debt	126.75	77.17	141.74	115.14	36.09
Net Cash (Debt)	2,263	865.08	963.87	711.19	1,003
Net Cash Growth	161.60%	-10.25%	35.53%	-29.07%	61.07%
Net Cash Per Share	18.64	7.64	8.67	6.49	9.60
Filing Date Shares Outstanding	129.19	113.34	113.09	109.92	109.27
Total Common Shares Outstanding	129.19	113.34	113.09	109.92	109.27
Working Capital	2,251	992.7	1,146	765.37	1,005
Book Value Per Share	24.05	11.61	12.31	8.83	10.00
Tangible Book Value	3,106	1,315	1,392	970.72	1,093
Tangible Book Value Per Share	24.04	11.61	12.31	8.83	10.00
Land	-	49.69	155	155	49.69
Buildings	-	52.95	69.59	69.23	53.22
Machinery	-	63.43	56.76	54.91	54.13
Construction In Progress	-	-	-	0.54	-
Leasehold Improvements	-	3.75	3.75	3.75	3.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.